RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Allergan Inc.

A collection of news and information related to Allergan Inc. published by this site and its partners.

Top Allergan Inc. Articles

Displaying items 12-22
  • Valeant hikes its takeover offer for Allergan

    For weeks, Valeant Pharmaceuticals had promised a better offer for Botox maker Allergan, but its renewed cash-and-stock offer fell flat with investors and analysts. After Irvine-based Allergan Inc. rejected a $46-billion offer earlier this month, the...
  • Valeant again raises bid for Allergan

    Valeant again raises bid for Allergan
    For the second time in a week, Canadian drug maker Valeant Pharmaceuticals has raised its offer to acquire Botox maker Allergan Inc.  The revised offer issued Friday now lifts the proposed deal value to about $53 billion, up from Wednesday's bid of...
  • Valeant raises offer for Allergan for 2nd time this week

    For the second time in a week, Canadian drug maker Valeant Pharmaceuticals has raised its offer to acquire Botox maker Allergan Inc. The revised offer issued Friday lifts the proposed deal's value to about $53 billion, up from Wednesday's bid of about...
  • Bid for Allergan turns hostile as Ackman calls for shareholder meeting

    The jockeying for control of Botox maker Allergan Inc. is getting downright hostile — and even more bizarre. Activist investor Bill Ackman called for a special meeting at which Allergan shareholders could potentially vote out the bulk of the...
  • Ackman turns up heat on Allergan, calls for shareholder meeting

    The jockeying for control of Botox maker Allergan Inc. is getting nastier. Activist investor Bill Ackman called Monday for a special meeting at which Allergan shareholders could potentially vote out the bulk of the Irvine company's board of directors....
  • Commentary: Why residents want to 'draft Duffy' for City Council

    With no offense to Diane Dixon versus Michael Glenn, or Michael Toerge versus Scott Peotter, or even Tim Brown versus Roy Englebrecht, we may soon have a Newport Beach City Council race to watch. On Wednesday, the "Draft Duffy" movement will start with a...
  • Allergan adopts 'poison pill' defense in Valeant takeover bid

    Takeover target Allergan Inc., the company that makes Botox, has adopted a "poison pill" defense intended to delay a buyout by Canadian company Valeant Pharmaceuticals International Inc. and activist investor Bill Ackman. The Irvine company's...
  • Ackman warns Allergan on offer

    Activist investor Bill Ackman warned Botox maker Allergan Inc. on Monday that it would be unwise to court potential acquirers as an alternative to the offer that he and Valeant Pharmaceuticals International Inc. have made for the company. Last month,...
  • Allergan questions viability, experience of would-be buyer Valeant

    A day before would-be buyer Valeant Pharmaceuticals is set to unveil a second, unsolicited takeover bid, its acquisition target, Allergan Inc., sought to discredit the company by filing a presentation with regulators questioning the viability of Valeant's...
  • Allergan steps up attack on Valeant

    The billion-dollar takeover battle targeting Irvine-based Allergan is heading into high gear this week with both sides on the attack. On Tuesday, Allergan Inc., the maker of Botox, launched a broadside against Canadian rival Valeant Pharmaceutics...
  • Ackman, Valeant partnering in bid to acquire Botox maker Allergan

    Activist investor Bill Ackman is partnering with Valeant Pharmaceuticals in an attempt to buy Orange County pharmaceutical company Allergan Inc., which sells the popular wrinkle treatment Botox. Ackman’s Pershing Square Capital Management said...